Clot shot “vaccines” create BOOM in blood clot removal industry – Dr. Eddy Bettermann MD

Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to treat blood clots caused by Pfizer, Moderna and J&J coronavirus “vaccines.” This type of blood clot removal is a faster treatment option than the traditional CDT (catheter-directed thrombolysis) or lytic (thrombolytic) procedures. Yes, the “image-guided” blood clot therapy business is skyrocketing, and certain companies are all over it, making a fortune, while buying out other companies and investing heavily in specific equipment and implantable devices, and thus expanding their “portfolio.”

Philips acquired Intact Vascular in the third quarter of 2020 with $275 million in cash and another $85 million after completion, expanding the company’s blood clot tech business just in time for the apocalyptic rush of mysterious blood clot incidents following the mass (forced) vaccination program across the nation. Now, just like the pacemaker market, the blood clot tech market is taking off. Who knew about all the myocarditis and blood clot side effects of the vaccines before they even came out?

There’s big money in treating blood clots, so why not capitalize early on a wave of blood clots that come from getting gene therapy injections for Wuhan Virus? After all, America is built on capitalism. The patient population that needs blood clot therapy has exponentially expanded, including young healthy people, athletes, military members and even children, thanks to the Fauci Flu clot shots. There are aspiration pumps and catheters for those hard to reach clots in peripheral veins and arteries. Big Pharma’s got you covered. They planned well for it. The FDA cleared the whole industry for pre-pandemic “take off.”

Clot shot “vaccines” create BOOM in blood clot removal industry – Dr. Eddy Bettermann MD